TNDMTandem Diabetes Care, Inc.
19.33USD+13.31%Mkt Cap: 1.34B USDP/E: Last update: 2026-06-01

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery sy…

Indicators:|

Key Statistics

Company
Market Cap1.34B USD
Enterprise Value1.34B USD
Revenue (TTM)1.03B USD
Gross Profit546.01M USD
Net Income (TTM)-204.71M USD
Revenue/Share15.16 USD
Last Price19.33 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS8753722037
Valuation
P/E (Trailing)
P/E (Forward)346.01
PEG
EV/EBITDA-31.09
EV/Revenue1.31
P/S1.15
P/B7.57
EPS (TTM)-1.37
EPS (Forward)0.05
52W Range
9.98048% of range29.65
52W High29.65 USD
52W Low9.980 USD
Profitability
Gross Margin53.81%
Oper. Margin-7.05%
EBITDA Margin-4.21%
Profit Margin-20.17%
ROE-131.93%
ROA-23.23%
Growth
Revenue Growth5.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-9.72M USD
CapEx (TTM)98.54M USD
FCF Margin-1.97%
FCF Yield-1.51%
Net Debt164.48M USD
Net Debt/EBITDA-3.81
Balance Sheet
Debt/Equity2.86
Current Ratio3.58
Quick Ratio2.87
Book Value/Sh2.272 USD
Cash/Share8.321 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateOct 10, 2017
Splits
Last Split1:10
Split DateOct 10, 2017
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)30.14 USD
Target Range17.00 USD55.00 USD
# Analysts21
Ownership
Shares Out.68.53M
Float62.93M
Insiders0.97%
Institutions117.90%
Short Interest
Short Ratio4.5d
Short % Float21.22%
Short % Out.15.76%
Shares Short10.80M
Short (prev mo.)9.64M
Technical
SMA 5018.91 (+2.2%)
SMA 20018.09 (+6.9%)
Beta1.64
S&P 52W Chg27.70%
Avg Vol (30d)2.47M
Avg Vol (10d)3.19M
Technical Indicators
RSI (14)52.4
MACD-0.9579
MACD Signal-1.3216
MACD Hist.+0.3638
BB Upper20.10 USD
BB Middle15.85 USD
BB Lower11.61 USD
BB Width53.56%
ATR (14)1.296 USD
Vol Ratio (20d)0.61x